Abstract
A rapid, specific, and sensitive ultra-performance liquid chromatographic method for analysis of levofloxacin in human plasma has been developed and validated. Plasma samples were spiked with the internal standard (enoxacin) and extracted with 10:1 (v/v) ethyl acetate–isopropanol. UPLC was performed on a 100 × 2.1 mm i.d., 1.7 µm particle, C18 column with 88:12 (v/v) 0.4% triethylamine buffer (pH 3)–acetonitrile as mobile phase, pumped isocratically at a pressure of 11,000 psi (758 bar) and a flow-rate of 0.3 mL min−1. Ultraviolet detection was performed at 300 nm. The retention times of levofloxacin and enoxacin were 3.4 and 2.8 min, respectively, and the run-time was 5 min. Calibration showed that response was a linear function of concentration over the range 0.05–10 µg mL−1 (r 2 ≥ 0.99) and the method was validated over this range for both precision and accuracy. The relative standard deviation was <15% for both intra-day and inter-day assay (n = 5). Levofloxacin and enoxacin were stable in plasma; there was no evidence of degradation during three freeze–thaw cycles, post-preparative stability at 20 °C was ≥24 h, short-term stability at room temperature was ≥6 h, and long-term stability at −70 °C was ≥30 days. The method was successfully used in a study of the bioequivalence of two levofloxacin tablet formulations in healthy volunteers.
Similar content being viewed by others
References
Wong FA, Juzwin SJ, Flor SC (1997) J Pharm Biomed Anal 15:765–771. doi:10.1016/S0731-7085(96)01890-0
Bellmann R, Kuchling G, Dehghanyar P, Zeitlinger M, Minar E, Mayer BX, Muller M, Joukhadar C (2004) Br J Clin Pharmacol 57:563–568. doi:10.1111/j.1365-2125.2004.02059.x
Pea F, Pavan F, Nascimben E, Benetton C, Scotton PG, Vaglia A, Furlanut M (2003) Antimicrob Agents Chemother 47:3104–3108. doi:10.1128/AAC.47.10.3104-3108.2003
Rodvold KA, Danziger LH, Gotfried MH (2003) Antimicrob Agents Chemother 47:2450–2457. doi:10.1128/AAC.47.8.2450-2457.2003
Zhanel GG, Noreddin AM (2001) Curr Opin Pharmacol 1:459–463. doi:10.1016/S1471-4892(01)00080-7
Djabarouti S, Boselli E, Allaouchiche B, Ba B, Nguyen AT, Gordien JB, Bernadou JM, Saux MC, Breilh D (2004) J Chromatogr B 799:165–172. doi:10.1016/j.jchromb.2003.10.031
Wren SA, Tchelitcheff P (2006) J Chromatogr A 1119:140–146. doi:10.1016/j.chroma.2006.02.052
Villiers de A, Lestremau F, Szucs R, Gelebart S, David F, Sandra P (2006) J Chromatogr A 1127:60–69. doi:10.1016/j.chroma.2006.05.071
Petrovic M, Gros M, Barcelo D (2006) J Chromatogr A 1124:68–81. doi:10.1016/j.chroma.2006.05.024
O’Connor D, Mortishire-Smith R, Morrison D, Davies A, Dominguez M (2006) Rapid Commun Mass Spectrom 20:851–857. doi:10.1002/rcm.2385
Wren SA (2005) J Pharm Biomed Anal 38:337–343. doi:10.1016/j.jpba.2004.12.028
Chien SC, Wong FA, Fowler CL, Callery-D’Amico SV, Williams RR, Nayak R, Chow AT (1998) Antimicrob Agents Chemother 42:885–888
Chien SC, Rogge MC, Gisclon LG, Curtin C, Wong F, Natarajan J, Williams RR, Fowler CL, Cheung WK, Chow AT (1997) Antimicrob Agents Chemother 41:2256–2260
Carlucci G (1998) J Chromatogr A 812:343–367. doi:10.1016/S0021-9673(98) 00274-X
KFDA Guidance for industry, Statistical approaches to establishing bioequivalence, Bioequivalence Division, Pharmacology Department, National Institute of Toxicology Department, 2003, website: http://www.kfda.go.kr/
FDA Guidance for industry, Statistical approaches to establishing bioequivalence, US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), 2001, website: http://www.fda.gov/cder/guidance/index.htm
Lubasch A, Keller I, Borner K, Koeppe P, Lode H (2000) Antimicrob Agents Chemother 44:2600–2603. doi:10.1128/AAC.44.10.2600-2603.2000
Zhou ZL, Yang M, Yu XY, Peng HY, Shan ZX, Chen SZ, Lin QX, Liu XY, Chen TF, Zhou SF, Lin SG (2007) Biomed Chromatogr 21:1045–1051. doi:10.1002/bmc.851
Acknowledgments
This research was supported by a grant from the Kyungpook National University Research Fund 2005 and the Korea Health 21 Research and Development Project, Ministry of Health and Welfare, Republic of South Korea (A050584) and by the Brain Korea 21 Project.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Park, DJ., Phapale, P.B., Jang, IJ. et al. An Improved UPLC Method for Rapid Analysis of Levofloxacin in Human Plasma. Chroma 68, 187–192 (2008). https://doi.org/10.1365/s10337-008-0669-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1365/s10337-008-0669-4